#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rhabdomyosarcoma Salivary gland cancer Tuberous sclerosis complex Paraneoplastic neurological syndrome Congenital hypotransferrinaemia Chronic myeloid leukaemia Chorioretinitis Prader-Willi syndrome Acute lymphocytic leukaemia recurrent T-cell lymphoma Glomerulonephritis rapidly progressive Congenital cystic kidney disease Pleural mesothelioma malignant Immune-mediated myositis Narcolepsy More trials…

    Learn about Rare Diseases

    Ornithine transcarbamoylase deficiency – Trials in Disease Andersen-Tawil syndrome – Diagnostics Langerhans cell sarcoma – Life with Disease Hairy cell leukaemia recurrent – Life with Disease Turner’s syndrome – Trials in Disease Primary immunodeficiency syndrome – Basic Information Adrenocortical carcinoma – Trials in Disease Osteosarcoma recurrent – Trials in Disease Progressive multifocal leukoencephalopathy – Treatment Hepatic angiosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    H2-Receptor Antagonist PIROXICAM Auto4 Acp-204 Tartrate Follitropin Delta Goserelin Tolinapant Lactate Dyp688 Mianserin Hydrochloride Ibutamoren Mesilate Pseudoephedrine Hydrochloride Hhalpc Emiplacel Tusamitamab Ravtansine Rebisufligene Etisparvovec Desflurane Sar442970 Rapcabtagene Autoleucel Abt-494 Trandolapril More therapies…

    Learn about Your Condition

    Solitary fibrous tumour Hodgkin's disease Actinic cheilitis Systemic candida Extraskeletal ossification Chronic coronary syndrome Biotinidase deficiency Organ donor Breast cancer stage IV Peptostreptococcus infection Malformation venous Alagille syndrome Tympanic membrane hyperaemia Atopic keratoconjunctivitis Endocrine ophthalmopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effectiveness and Safety of Sirolimus for Patients with Drug-Resistant Epilepsy Linked to Tuberous Sclerosis Complex

    Recruiting

    3 1 1
    Investigated Diseases:
    • Tuberous sclerosis complex
    • Epilepsy
    Investigated Drugs:
    • Sirolimus
    Poland

  • Study on Psilocybin for Relieving Chronic Neuropathic Pain in Patients with Chemotherapy-Induced Peripheral Neuropathy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neuralgia
    • Neuropathy peripheral
    Investigated Drugs:
    • Oxazepam
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    The Netherlands

  • Study on the Effects of Intraperitoneal Furosemide in Patients with Heart Failure on Peritoneal Dialysis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure
    Spain

  • Study on the Safety of Roginolisib and Ruxolitinib for Patients with Myelofibrosis Unresponsive to JAK Inhibitors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Myelofibrosis
    Investigated Drugs:
    • Fedratinib
    • Roginolisib
    • Momelotinib Dihydrochloride Monohydrate
    Italy Spain

  • Study of Durvalumab with chemotherapy (paclitaxel, cisplatin, carboplatin, vinorelbine) in patients with stage IIIA/B non-small cell lung cancer that can be removed by surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    • Non-small cell lung cancer stage IIIA
    • Non-small cell lung cancer stage IIIB
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Durvalumab
    Germany

  • Study Comparing Sodium Chloride and Sodium Lactate for Treating Severe Diabetic Ketoacidosis in ICU Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetic ketoacidosis
    Investigated Drugs:
    • Sodium Lactate
    • Sodium Chloride
    France
Previous Page
1 … 266 267 268 269 270 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!